ARCHIVES

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

Cancer Screening Priorities Questioned In Dartmouth Study

March 28, 2003

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

August 1, 2014

Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks

May 5, 1995

Adcetris Granted Approval For Hodgkin’s Lymphoma and ALCL

September 30, 2011

Journals Probe Whether Rush University Official Broke Publication Embargo In Pro-CT Editorial.

June 6, 2008

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014